Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
ChiCTR2600133468Phase 4Not yet recruiting
- Sponsor
- Zizhong County People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glycopyrronium in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Zizhong County People's Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting within 24 hours after surgery. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
glycopyrronium
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600133468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133468.